kentucky semaglutide pancreatitis law firm glp-1 in Risk of pancreatic cancer associated with receptor agonist therapy GLP-1 Agonists and Pancreatitis Risk – kentucky gastrointestinal obstruction law – semaglutide gastric stasis law firm

In a study published in 2004, Nikolaidis et al

Atherosclerosis 191(2):391396

Mounjaro may contribute to an increased risk for thyroid c-cell tumors, acute pancreatitis, gallbladder disease, hypoglycemia, acute kidney injury, severe GI side effects, hypersensitivity reactions, worsening of diabetic retinopathy if you have type 2 diabetes

You can spot a real plateau by looking for these signs

Increased risk with higher serum POP levels has also been found for the development of cardiovascular disease, hypertension, insulin resistance, and the metabolic syndrome

If you suspect you have experienced a side effect, you can report it to the MHRA via the Yellow Card Scheme at yellowcard.mhra.gov.uk or through the Yellow Card app